Rodman & Renshaw Maintains Spectranetics Market Outperform, $9 PT

Rodman & Renshaw maintained its Spectranetics SPNC Market Outperform rating and $9 price target in a research report published today. In the report, Rodman & Renshaw states, "We are curious of what new strategic initiatives the new CEO will be embarking upon. To us, the next two quarterly calls will be very telling about the next leg up for this story." Shares of Spectranetics were trading at $7.20 at the time of posting, up 9.76% from Wednesday's market close.